Could you clarify how the controls for trial acceptance, capability, and unresolved risks will be verified and who will approve the mass-production release?

PCBA Engineering & NPIMass Production ReleaseB1polite

ช่วยชี้แจงได้ไหมว่าจะ Verify การควบคุมเรื่อง ผล Trial, Capability และความเสี่ยงที่ยังเปิดอยู่ อย่างไร และใครจะเป็นผู้อนุมัติการ Release Mass Production

แกะรูปประโยค

สถานการณ์ / Intent

Meeting clarification

Grammar / Pattern

indirect question

คำศัพท์สำคัญ

mass-production release; trial acceptance, capability, and unresolved risks

ระดับภาษา

B1 · polite

ใช้ประโยคนี้อย่างไร

Indirect Question ทำให้คำถามสุภาพและมืออาชีพขึ้น โดยหลัง how/who ใช้โครงประโยคปกติ ไม่กลับคำแบบคำถามซ้อน

พูด/เขียนได้หลายแบบ

FORMAL

Please ensure that the mass-production release is fully verified against the approved requirements for trial acceptance, capability, and unresolved risks before release.

CASUAL

Can we check the mass-production release and close the remaining points on trial acceptance, capability, and unresolved risks?

ALTERNATIVE

For the mass-production release, confirm the latest revision, the cut-in point, validation evidence, and any open risk before release.

Grammar Reference

Indirect Questions for Professional CommunicationIndirect Question สำหรับถามแบบมืออาชีพ · Could you confirm / Do you know + question clause Indirect Questions for ClarificationIndirect Question สำหรับถามอย่างมืออาชีพ · Could you clarify why/when/whether + subject + verb...?Do / Does / Did for questions and negativesDo / Does / Did สำหรับถามและปฏิเสธ · Do/Does/Did + subject + base verb...?

แกะรูปประโยค

ใช้ประโยคนี้อย่างไร

พูด/เขียนได้หลายแบบ

Grammar Reference

ประโยคใกล้เคียง

Do not release the mass-production release until the latest revision, cut-in point, validation evidence, and open risks have been reviewed with the responsible functions.

Before the next release, verify the controls for trial acceptance, capability, and unresolved risks in the mass-production release.

The team is reviewing the controls for trial acceptance, capability, and unresolved risks as part of the mass-production release.

We found a gap in the mass-production release: one or more controls related to trial acceptance, capability, and unresolved risks do not match the approved requirement.

If the mass-production release is not closed before the next build, the unresolved points around trial acceptance, capability, and unresolved risks may create a production or quality risk.

We have completed the initial review of the mass-production release and assigned owners for the remaining actions related to trial acceptance, capability, and unresolved risks.

We would appreciate it if you could provide the latest evidence for the mass-production release, including the status of trial acceptance, capability, and unresolved risks, by 3 p.m. today.

For management review, the main open point in the mass-production release is the control of trial acceptance, capability, and unresolved risks; the immediate risk is contained, and the team is working toward final closure.